Company Overview
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment produces and sells potash, salt, magnesium, electricity, and magnesium alloys; as well as chlorine and sylvinite. The Phosphate segment uses phosphate commodity products to produce specialty products; sells phosphate-based fertilizers, as well as sulphuric and green phosphoric acid, and phosphate fertilizers; and offers phosphate salts and acids. It also develops and produces functional food ingredients and phosphate additives. The Growing Solutions segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water-soluble specialty, and controlled-release fertilizers, as well as secondary nutrients, bio-stimulants, soil conditioners, seed treatment products, and adjuvants. It also offers digital platforms and technological solutions for farmers and agronomists. The company serves pharmaceutical, food, oil and gas, de-icing, building and construction, oral care, paints and coatings, energy storage, water treatment, electronics, automotive, agriculture, textiles, tire manufacturing, and healthcare industries, as well as power plants and battery producers. It sells its products through marketing companies, agents, and distributors. The company was formerly known as Israel Chemicals Ltd. and changed its name to ICL Group Ltd in May 2020. The company was incorporated in 1968 and is headquartered in Tel Aviv-Yafo, Israel.
Why Investors Should Care
Offers a dividend yield of 3.72%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $7.15B (+4.6% YoY); net profit $226.00M.
- Trailing 12 Months Year-on-year growth — revenue +16.5%, earnings +51.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -10.6%, profit CAGR -52.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -10.61% |
| 1 Year: | 16.50% |
Compounded Profit Growth
| 5 Years: | -52.87% |
| 1 Year: | 51.60% |
Stock Price Performance
| 1 Year: | -2.12% |
| 6 Months: | +12.76% |
| 3 Months: | +5.89% |
| 1 Month: | +11.48% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)67.47 · Neutral
P/E of 24.42 is above the sector median of 22.16 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Attractive dividend yield of 3.72%.
- Generates positive free cash flow.
CONS
- Revenue declined at -10.6% CAGR over 5 years.
- Earnings shrank at -52.9% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ICL ICL Group Ltd | 5.86 | 24.42 | $7.56B | 3.72% | 7.41% | 5.63% | -10.61% | -52.87% |
| 2 | LIN Linde plc NDXSPXR3K | 468.38 | 30.22 | $215.91B | 1.40% | 12.46% | 18.40% | 13.90% | 18.47% |
| 3 | SCCO Southern Copper Corporation R3K | 208.56 | 31.27 | $176.10B | 2.24% | 36.40% | 49.90% | 8.32% | 3.80% |
| 4 | NEM Newmont Corporation SPXR3K | 127.09 | 16.01 | $133.91B | 0.84% | - | 25.91% | 6.53% | 20.15% |
| 5 | RIO Rio Tinto Group | 103.83 | 14.07 | $130.27B | 4.78% | 13.65% | 19.31% | 1.24% | -7.00% |
| 6 | FCX Freeport-McMoRan Inc. SPXR3K | 76.62 | 37.56 | $110.03B | 0.78% | 12.50% | 14.75% | 1.35% | -1.26% |
| 7 | AEM Agnico Eagle Mines Limited | 201.84 | 17.27 | $102.20B | 0.88% | 19.78% | 22.97% | 27.53% | 88.11% |
| 8 | SHW The Sherwin-Williams Company SPXR3K | 326.09 | 30.05 | $79.16B | 1.00% | 21.93% | 65.12% | 6.18% | 8.26% |
| 9 | ECL Ecolab Inc. SPXR3K | 278.11 | 37.33 | $77.96B | 1.05% | 15.10% | 21.96% | 6.55% | 9.74% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.77B | 1.83B | 1.85B | 1.70B | 2.02B |
| Cost of Revenue | - | 1.21B | 1.28B | 1.25B | 1.23B | 1.40B |
| Gross Profit | - | 560.00M | 554.00M | 604.00M | 468.00M | 626.00M |
| Operating Expenses | - | 363.00M | 365.00M | 379.00M | 391.00M | 392.00M |
| Operating Income | - | 197.00M | 189.00M | 225.00M | 77.00M | 234.00M |
| EBITDA | - | 361.00M | 416.00M | 388.00M | 39.00M | 414.00M |
| Interest Expense | - | 62.00M | 98.00M | 45.00M | -57.00M | 61.00M |
| Pretax Income | - | 148.00M | 168.00M | 186.00M | -61.00M | 193.00M |
| Tax Provision | - | 42.00M | 60.00M | 57.00M | 2.00M | 53.00M |
| Net Income | - | 91.00M | 93.00M | 115.00M | -73.00M | 126.00M |
| Diluted EPS | - | 0.07 | 0.07 | 0.09 | -0.06 | 0.10 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 10.02B | 7.54B | 6.84B | 7.15B |
| Cost of Revenue | - | 4.98B | 4.87B | 4.58B | 4.97B |
| Gross Profit | - | 5.03B | 2.67B | 2.26B | 2.19B |
| Operating Expenses | - | 1.55B | 1.43B | 1.45B | 1.50B |
| Operating Income | - | 3.48B | 1.25B | 802.00M | 688.00M |
| EBITDA | - | 4.04B | 1.67B | 1.38B | 1.20B |
| Interest Expense | - | 138.00M | 160.00M | 146.00M | 148.00M |
| Pretax Income | - | 3.40B | 974.00M | 636.00M | 441.00M |
| Tax Provision | - | 1.19B | 287.00M | 172.00M | 161.00M |
| Net Income | - | 2.16B | 647.00M | 407.00M | 226.00M |
| Diluted EPS | - | 1.67 | 0.50 | 0.32 | 0.18 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 11.75B | 11.63B | 11.32B | 12.41B |
| Current Assets | - | 4.55B | 4.03B | 3.59B | 4.16B |
| Cash & Equivalents | - | 417.00M | 420.00M | 327.00M | 291.00M |
| Inventory | - | 2.13B | 1.70B | 1.63B | 1.93B |
| Receivables | - | 1.58B | 1.38B | 1.26B | 1.36B |
| Total Liabilities | - | 6.04B | 5.59B | 5.33B | 6.17B |
| Current Liabilities | - | 2.61B | 2.64B | 2.33B | 3.13B |
| Long Term Debt | - | 2.11B | 1.62B | 1.72B | 1.70B |
| Total Debt | - | 2.82B | 2.69B | 2.29B | 2.76B |
| Total Equity | - | 5.46B | 5.77B | 5.72B | 5.98B |
| Shares Outstanding | - | 1.31B | 1.31B | 1.31B | 1.32B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 2.13B | 1.71B | 1.47B | 1.06B |
| Investing Cash Flow | - | -747.00M | -853.00M | -694.00M | -915.00M |
| Financing Cash Flow | - | -1.42B | -837.00M | -846.00M | -195.00M |
| Capital Expenditure | - | -747.00M | -780.00M | -713.00M | -824.00M |
| Free Cash Flow | - | 1.38B | 930.00M | 755.00M | 232.00M |
| Net Change in Cash | - | -32.00M | 20.00M | -72.00M | -54.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 50.2% | 35.4% | 33.0% | 30.6% |
| Operating Margin % | - | 34.8% | 16.5% | 11.7% | 9.6% |
| Net Margin % | - | 21.6% | 8.6% | 5.9% | 3.2% |
| ROE % | - | 39.5% | 11.2% | 7.1% | 3.8% |
| ROCE % | - | 38.1% | 13.9% | 8.9% | 7.4% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Altshuler Shaham Ltd | 1.86% | 23.97M | $128.50M |
| 2 | NORGES BANK | 1.65% | 21.30M | $114.16M |
| 3 | Vanguard Capital Management LLC | 1.62% | 20.92M | $112.12M |
| 4 | Clal Insurance Enterprises Holdings Ltd | 1.54% | 19.81M | $106.20M |
| 5 | Y.D. More Investments Ltd | 1.51% | 19.50M | $104.51M |
| 6 | Phoenix Financial Ltd. | 1.21% | 15.58M | $83.52M |
| 7 | Morgan Stanley | 0.76% | 9.84M | $52.73M |
| 8 | Vanguard Fiduciary Trust Co | 0.50% | 6.46M | $34.61M |
| 9 | Blackrock Inc. | 0.44% | 5.73M | $30.74M |
| 10 | Goldman Sachs Group Inc | 0.42% | 5.48M | $29.36M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ICL
Why ICL Group (ICL) is a Top Dividend Stock for Your Portfolio - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPM2gtZGUzaW1fcnlZLVlOWlRhSmo4Q0VWN3pFYzFHeHo2Z0JXS1VsT2hub0J1TmlUZGhhM08wNllaOFRhQkVpZjROS1FfR1RpRndwSVVKMDZFZ2FNbl9QLWNIdkdZck1iS29jU01TdlhVVFNIZHRjc3RPSzUzcWxxRGpDMnBFS2UxMkI1ME…
Is ICL Group’s Tailored Dividend Policy Refining Its Capital Allocation Story For ICL (ICL)? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxOdWNtXy1RbHBDSzBYU3pkQjFNT1o4NlpTOC1RcVBPd1RyeDB6UkcxZXNWc1NTWVJPVlB5NXlmc1FnaGtnT0xfWmlMYjhyZEdUNHFZdmdMVV9sWnVLQmtvZTA2OVVGZ29mOUwtR0dyc1pLdk5IbXl3bzV6SWhaQTNVeG9RLUhHRmdNUy1STW…
Understanding the Setup: (ICL) and Scalable Risk - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNa1lTT2RlcUI5REQtN19ZcXQ2M0ZjWTNzX2dHbnFJVEFiSUFIWHFhbDZsMnZCa2JGajBGdlI5QVEyNmFLRVVTeFlqU0JFSUhZczMzZmk4c3hGV2NmSk9YZVI3blVHNi1XNk82cUZUTjNSMDFMbDYwZEEwOWM1SDlweGVROUZwOXR5bkJyRn…
ICL Group Details $75 Million Dividend and Withholding Tax Terms for September 2026 Payout - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMigwJBVV95cUxONjFoa2c0dHJrYVFxT0JjVlhnVGo5TjJDVkZOYUZQMDRYMlFNR1lDZllrUXg5ZkppZXIzV0IydzZjQnVkaFE3Vi1hQkVvTVZxWHhJWUszT3Jvb3UwWmVPR2RGVGp3UTdCOHloZEFhaHZ3dXdSbzN6SUVxUEd1VE9CSl96VHRJeU9uQXlwZW…
ICL Group Remains Fundamentally Attractive, But My Caution Was Correct - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOWnM0cTh6eWs4aGh1dkdVOEJhcU9sbVpPcDkydkhmZmNTSVRnWi1PeTByVjJrU0xBZFdELXkwTERjLUZCTDlTcF9sQ25TdmplcDdWdUdNZTFtNEJRWWtJdnFSYTgxcGVraWc3MTdRZXRiMm5GR213LVRKTy12UVlxUEFqQUtFN0FJeUJwQj…
ICL - ICL Group Ltd Stock Price and Quote - Finviz
<a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE5kZE5SVVNCLVhsMC16bmlNb1MwOW8wVzhWNTc4bTNLT3VXNEZWd05TczJQLWxYMDlXTEtlQXBoampiNHRW?oc=5" target="_blank">ICL - ICL Group Ltd Stock Price and Quote</a> <font color="#6f6f…
ICL — Frequently Asked Questions
What is the current share price of ICL Group Ltd (ICL)?
As of 2026-09-19 21:16 PDT, ICL Group Ltd (ICL) trades at $5.86 on NYSE. Its 52-week range is $4.67 to $6.70.
What is the market capitalisation of ICL?
ICL Group Ltd (ICL) has a market capitalisation of $7.56B on NYSE.
What is the P/E ratio of ICL?
ICL trades at a trailing price-to-earnings (P/E) ratio of 24.42. The industry average P/E is 22.16. Its price-to-book (P/B) ratio is 1.13.
Does ICL pay a dividend?
ICL Group Ltd (ICL) currently offers a dividend yield of 3.72%.
What is the return on equity (ROE) of ICL?
ICL has a return on equity (ROE) of 5.63%. Its return on capital employed (ROCE) is 7.41%.
Is ICL a good stock to buy?
This page provides a data-driven analysis of ICL Group Ltd (ICL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.